IDEXX Laboratories Aktie

IDEXX Laboratories für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 888210 / ISIN: US45168D1046

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
03.11.2025 12:44:54

IDEXX Laboratories Inc Q3 Profit Increases, Beats Estimates

(RTTNews) - IDEXX Laboratories Inc (IDXX) announced earnings for its third quarter that Increased from the same period last year and beat the Street estimates.

The company's earnings totaled $274.61 million, or $3.40 per share. This compares with $232.84 million, or $2.80 per share, last year.

Excluding items, IDEXX Laboratories Inc reported adjusted earnings of $3.22 per share for the period.

Analysts on average had expected the company to earn $3.14 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 13.3% to $1.105 billion from $975.54 million last year.

IDEXX Laboratories Inc earnings at a glance (GAAP) :

-Earnings: $274.61 Mln. vs. $232.84 Mln. last year. -EPS: $3.40 vs. $2.80 last year. -Revenue: $1.105 Bln vs. $975.54 Mln last year.

-Guidance: Full year EPS guidance: $12.81 - $13.01 Full year revenue guidance: $4,270 - $4,300 Mln

Analysen zu IDEXX Laboratoriesmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

IDEXX Laboratories 618,00 0,82% IDEXX Laboratories